https://newstodaylines.com/press-releases/aptevo-therapeutics-announces-exercise-of-existing-warrants-for-dollar30-million-grossNews Today Linesen2026-11-11T14:26:05.203ZAptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds https://newstodaylines.com/press-releases/pmet-resources-delivers-enhanced-cv5-lithium-tantalum-feasibility-studyNews Today Linesen2026-11-10T22:04:28.906ZPMET Resources Delivers Enhanced CV5 Lithium-Tantalum Feasibility Study https://newstodaylines.com/press-releases/alpha-pro-tech-ltd-announces-third-quarterNews Today Linesen2026-11-10T15:01:21.452ZALPHA PRO TECH, LTD. ANNOUNCES THIRD QUARTER https://newstodaylines.com/press-releases/zillows-2027-home-trends-report-digital-detox-colormaxxing-and-catiosNews Today Linesen2026-11-10T13:28:28.488ZZillow's 2027 Home Trends Report: Digital detox, 'colormaxxing' and catios https://newstodaylines.com/press-releases/cellectar-biosciences-reports-third-quarter-2026-financial-results-and-provides-corporateNews Today Linesen2026-11-10T12:53:50.555ZCellectar Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates https://newstodaylines.com/press-releases/ribo-submits-european-clinical-trial-application-for-a-novel-dual-targeting-sirna-sr122News Today Linesen2026-11-10T01:08:08.318ZRibo Submits European Clinical Trial Application for a Novel Dual Targeting siRNA SR122 for Mixed and Severe Dyslipidemia, Further Strengthening Its Footprint in the Area of Lipid Disorder https://newstodaylines.com/press-releases/mesa-labs-announces-second-quarter-fiscal-year-2027-results-and-issues-first-full-yearNews Today Linesen2026-11-09T21:47:45.540ZMesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance